Always the SECOND best reception @sitcancer …after The CheckPoints party, of course 😏 @PatrickHwuMD @MoffittNews know how to throw a party!…forgot my swim trunks though 🤷🏻♂️🤣 @jasonlukemd @wolchokj @BReinfeld @ipimama123 #SITC26
Russell Pachynski
@RPachynski
Associate Professor, Director of GU Oncology Research, Division of Oncology, Washington University STL; Tumor immunology/immunotherapy; views my own
419 Following 862 Followers 1.6K Posts
Latest posts 5
Thrilled to have joined @DanaFarber and to be working with an inspiring leader in oncology, @DrChoueiri. Delighted to serve as a faculty medical oncologist and Co-Director of the @Harvard Cancer Consortium #ProstateCancer Program. Excited for this new chapter!View quoted post on X
congrats Tian!! so well deserved! 🎉🤗
Promotion to Professor — an accomplishment I have worked for over many years, effective today. Thanks @suzanneconzenmd @carlosarteagamd & all colleagues around the world who wrote/called for me. Grateful beyond words. @drchoueiri @montypal @albigesL @ERPlimackMD @Daniel_J_GeorgeView quoted post on X
Amazing leadership @mpndoc congrats!!
Delighted to share that our NHLBI-supported Molecular Hematology T32 training grant has been officially renewed! 🎉Our program, now funded through Year 55, continues a long tradition of excellence in hematology research training @WashUHematology @WashUDeptMed @washumedicine. 🤩View quoted post on X
Thanks to @SurvivorNetTeam for the interview - a new mechanism of action drug for prostate cancer patients is great! Now we need to figure out how to make it work better for more patients! @SitemanCenter @WashUOncology @WashUDeptMed @Pachynski_Lab
The FDA approved a first-of-its-kind drug for aggressive prostate cancer. @WashUMedicine medical oncologist Russell Pachynski, MD, of Siteman tells @SurvivorNetTeam what it means for patients. survivornet.com/articles/the-f…View quoted post on X
